Form 144 Century Therapeutics For: 25 September
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Century Therapeutics Inc (IPSC)
Century Therapeutics Inc stock price live, this page displays NASDAQ IPSC stock exchange data. View the IPSC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Century Therapeutics Inc real time stock price chart below.
What Is the Century Therapeutics Inc Stock Price Today?
The Century Therapeutics Inc stock price today is 1.655.
What Is the Stock Symbol for Century Therapeutics Inc?
The stock symbol for Century Therapeutics Inc is "IPSC."
What Stock Exchange Does Century Therapeutics Inc Trade On?
Century Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Century Therapeutics Inc a Good Stock to Buy?
Determining whether Century Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPSC quote. (ISIN: US15673T1007)
What Is the Century Therapeutics Inc Stock Price Today?
The Century Therapeutics Inc stock price today is 1.655.
What Is the Stock Symbol for Century Therapeutics Inc?
The stock symbol for Century Therapeutics Inc is "IPSC."
What Stock Exchange Does Century Therapeutics Inc Trade On?
Century Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Century Therapeutics Inc a Good Stock to Buy?
Determining whether Century Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPSC quote. (ISIN: US15673T1007)
1.655
-0.015(-0.90%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.620
1.660
52 wk Range
0.435
3.040
IPSC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.6201.660
52 wk Range
0.4353.040
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IPSC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
4.750
Upside
+187.01%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Century Therapeutics appoints Joseph Truitt to board- Investing.com
Form 8K Century Therapeutics Inc For: 12 August- Investing.com
- Form 144 Century Therapeutics For: 25 September
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.750
(+187.01% Upside)
Earnings
Latest Release
Aug 12, 2026
EPS / Forecast
-0.17 / -0.11
Revenue / Forecast
-- / --
Compare IPSC to Peers and Sector
Metrics to compare | IPSC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPSCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | −2.5x | −0.4x | |
PEG Ratio | 0.02 | −0.04 | 0.00 | |
Price/Book | 1.3x | 1.5x | 2.6x | |
Price / LTM Sales | - | 8.5x | 3.1x | |
Upside (Analyst Target) | 184.4% | 416.3% | 57.4% | |
Fair Value Upside | Unlock | 14.7% | 7.7% | Unlock |
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Century Therapeutics (IPSC) Stock Price Today?
The Century Therapeutics stock price today is 1.655 USD.
What Stock Exchange Does Century Therapeutics Trade On?
Century Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Century Therapeutics?
The stock symbol for Century Therapeutics is "IPSC."
What Is the Century Therapeutics Market Cap?
As of today, Century Therapeutics market cap is 298.770M USD.
What Is Century Therapeutics's Earnings Per Share (TTM)?
The Century Therapeutics EPS (TTM) is -0.766.
When Is the Next Century Therapeutics Earnings Date?
Century Therapeutics will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is IPSC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Century Therapeutics Stock Split?
Century Therapeutics has split 0 times.
How Many Employees Does Century Therapeutics Have?
Century Therapeutics has 78 employees.
What is the current trading status of Century Therapeutics (IPSC)?
As of Sep 28, 2026, Century Therapeutics (IPSC) is trading at a price of 1.655 USD, with a previous close of 1.670 USD. The stock has fluctuated within a day range of 1.620 USD to 1.660 USD, while its 52-week range spans from 0.435 USD to 3.040 USD.
What Is Century Therapeutics (IPSC) Price Target According to Analysts?
The average 12-month price target for Century Therapeutics is 4.750 USD, with a high estimate of 8 USD and a low estimate of 2 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +187.01% Upside potential.
What Is the IPSC Premarket Price?
IPSC's last pre-market stock price is 1.770 USD. The pre-market share volume is 730.000, and the stock has decreased by 0.100, or 5.990%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.